Cronos (CRON) Liabilities and Shareholders Equity (2016 - 2026)
Cronos (CRON) recorded quarterly Liabilities and Shareholders Equity of $1.2 billion in Q1 2026, down 2.09% quarter-over-quarter from $1.2 billion in Q4 2025, and up 1.58% on a YoY basis from $1.2 billion in Q1 2025.
Cronos (CRON) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
Cronos' Liabilities and Shareholders Equity history runs 11 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 1.58% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $4.7 billion (up 2.78% YoY), while the FY2025 annual figure was $1.2 billion, up 2.64% from the prior year.
- Liabilities and Shareholders Equity was $1.2 billion for Q1 2026 at Cronos, down from $1.2 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.4 billion in Q1 2022 to a low of $1.1 billion in Q2 2024.
- Historically, Liabilities and Shareholders Equity has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2026.
- The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity slipped 27.12% in 2022, then rose 7.72% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.2 billion in 2022, then slipped by 6.0% to $1.1 billion in 2023, then gained by 2.28% to $1.2 billion in 2024, then grew by 2.64% to $1.2 billion in 2025, then fell by 2.09% to $1.2 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $1.2 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.04 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.15 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.71 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 555.95 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.91 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.22 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.26 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.27 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.35 Bn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Bn |
| Dec 31, 2025 | 1.20 Bn |
| Sep 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | 1.15 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.11 Bn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 1.15 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.24 Bn |
| Jun 30, 2022 | 1.33 Bn |
| Mar 31, 2022 | 1.37 Bn |
| Dec 31, 2021 | 1.40 Bn |
| Sep 30, 2021 | 1.54 Bn |
| Jun 30, 2021 | 1.60 Bn |